je.st
news
Positive clinical data of CytRx's aldoxorubicin to be presented at ASCO 2015
2015-05-27 21:43:05| Logistics - Topix.net
CytRx Corporation , a biopharmaceutical research and development company specializing in oncology, today announced an upcoming poster presentation regarding its lead drug candidate, aldoxorubicin, at the 2015 American Society of Clinical Oncology Annual Meeting, which is being held May 29 - June 2, 2015 in Chicago. "I am impressed by the excellent long-term cardiac safety profile we're seeing in patients who have undergone treatment with aldoxorubicin across several cancer types," said Sant P. Chawla, M.D., F.R.A.C.P., Principal Investigator and Director of the Sarcoma Oncology Center.
Tags: data
positive
presented
clinical
Category:Transportation and Logistics
Latest from this category |
All news |
||||||||||||||||||
|